FOR IMMEDIATE RELEASE:
4 August 2020
CONTACTS:
Asian Fund for Cancer Research
Bradley Gillenwater, Senior Director for Global Programs & Communications
E-mail: bgillenwater@afcr.org
Hugill & Ip Solicitors
Marco Raccuia, Head of Finance & Operations
E-mail: marco.raccuia@hugillandip.com
Applications Open for the Asian Fund for Cancer Research’s BRACE Award Venture Competition
First of…
It has long been believed that herbs and spices offer far more than delicious flavor. Cultures around the world have used herbs and spices for a large array of activities, from medical treatment to religious practices. In fact, it was spices that…
Michael Wang, MD., Ph.D., member of AFCR Scientific Advisory Board
The phased reopening in many states provides an opportunity to release the frustrations built up after staying-at-home for months. As summer begins, people are planning to take vacations, and many of them are…
We have completed six studies in the US and now we are doing an international clinical trial with a target population of hepatocellular carcinoma, which is the major type of liver cancer in Asia...
Read more: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7309656/
A healthy diet can impact many areas of health. A poor diet can increase the risk of the six most common types of cancer worldwide. There are many different sources telling many different stories about what a healthy diet and lifestyle look…
Michael Wang, MD., Ph.D., member of AFCR Scientific Advisory Board
Excitement spread quickly after a June 14 report that a COVID-19 vaccine developed by Imperial College London in the U.K. will be tested in humans. What excites people is that the vaccine, which…
Michael Wang, MD., Ph.D., member of AFCR Scientific Advisory Board
Many people were disappointed by recent high-profile clinical trial results on Remdesivir, the drug that people had put high hopes on as the best candidate for an effective COVID-19 treatment.
A report published in…
Michael Wang, MD., Ph.D., member of AFCR Scientific Advisory Board
The U.S. death toll has passed the 100,000 mark this week, but effective anti-viral drugs are still not available for the treatment of COVID-19. Rather, many people have been putting their hope on…
Often known as “the silent killer”, ovarian cancer is difficult to detect early because the ovaries are deep within the pelvis and initial symptoms are often ambiguous and non-specific. Too often the cancer goes undiagnosed until after the disease is far advanced…
Michael Wang, MD., Ph.D., member of AFCR Scientific Advisory Board
On February 11, weeks into the COVID-19 outbreak, the novel coronavirus was officially called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), as most patients showed mild to severe respiratory illness. Doctors shared the…